[Skip to Content]
[Skip to Content Landing]
Article
August 11, 1997

Clinical and Ethical Issues in the Treatment of a Jehovah's Witness With Acute Myeloblastic Leukemia

Arch Intern Med. 1997;157(15):1753-1757. doi:10.1001/archinte.1997.00440360189020
Abstract

We report the first documented case of the use of peripheral blood stem cell autografting in the treatment of a Jehovah's Witness with acute myeloblastic leukemia. This case illustrates the complex ethical and clinical issues that arise in the treatment of such patients.

Arch Intern Med. 1997;157:1753-1757

×